Skip to main content
TipRanks
Go Ultimate75% OFF

Sinco Pharmaceuticals Holdings Ltd. (6833) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Sinco Pharmaceuticals Holdings Ltd. has a market cap or net worth of HKD 237.85M. The enterprise value is HKD 164.08M.

Market Cap
HKD 237.85M
Enterprise Value
HKD 164.08M

Share Statistics

Sinco Pharmaceuticals Holdings Ltd. has 2,032,890,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
2,032,890,600
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Sinco Pharmaceuticals Holdings Ltd.’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 5.92%.

Return on Equity (ROE)
0.05
Return on Assets (ROA)
0.02
Return on Invested Capital (ROIC)
5.92%
Return on Capital Employed (ROCE)
0.10
Revenue Per Employee
8.11M
Profits Per Employee
135.61K
Employee Count
257
Asset Turnover
1.13
Inventory Turnover
7.17

Valuation Ratios

The current PE Ratio of Sinco Pharmaceuticals Holdings Ltd. is 6.44. Sinco Pharmaceuticals Holdings Ltd.’s PEG ratio is -0.24.

PE Ratio
6.44
PS Ratio
0.10
PB Ratio
0.27
Price to FCF
0.63
Price to Operating Cash Flow
0.62
PEG Ratio
-0.24

Income Statement

In the last 12 months, Sinco Pharmaceuticals Holdings Ltd. had revenue of 2.08B and earned 34.85M in profits. Earnings per share was 0.02.

Revenue
2.08B
Gross Profit
222.09M
Operating Income
72.00M
Pretax Income
48.26M
Net Income
34.85M
EBITDA
99.83M
Earnings Per Share (EPS)
0.02

Cash Flow

In the last 12 months, operating cash flow was 313.45M and capital expenditures -8.45M, giving a free cash flow of 305.00M billion.

Operating Cash Flow
313.45M
Free Cash Flow
305.00M
Free Cash Flow per Share
0.15

Dividends & Yields

Sinco Pharmaceuticals Holdings Ltd. pays an annual dividend of HKD 0.00, resulting in a dividend yield of 1.43%

Dividend Per Share
HKD 0.00
Dividend Yield
1.43%
Payout Ratio
8.70%
Free Cash Flow Yield
157.47%
Earnings Yield
15.69%

Stock Price Statistics

Beta
-0.20
52-Week Price Change
-41.21%
50-Day Moving Average
0.14
200-Day Moving Average
0.17
Relative Strength Index (RSI)
35.48
Average Volume (3m)
182.91K

Important Dates

Sinco Pharmaceuticals Holdings Ltd. upcoming earnings date is Mar 31, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 28, 2026
Next Earnings Date
Mar 31, 2027
Ex-Dividend Date
May 19, 2025

Financial Position

Sinco Pharmaceuticals Holdings Ltd. as a current ratio of 1.18, with Debt / Equity ratio of 26.42%

Current Ratio
1.18
Quick Ratio
0.95
Debt to Market Cap
0.57
Net Debt to EBITDA
-1.91
Interest Coverage Ratio
2.18

Taxes

In the past 12 months, Sinco Pharmaceuticals Holdings Ltd. has paid 13.41M in taxes.

Income Tax
13.41M
Effective Tax Rate
0.28

Enterprise Valuation

Sinco Pharmaceuticals Holdings Ltd. EV to EBITDA ratio is -0.65, with an EV/FCF ratio of -0.19.

EV to Sales
-0.03
EV to EBITDA
-0.65
EV to Free Cash Flow
-0.19
EV to Operating Cash Flow
-0.19

Balance Sheet

Sinco Pharmaceuticals Holdings Ltd. has HKD 369.41M in cash and marketable securities with HKD 116.76M in debt, giving a net cash position of HKD 252.65M billion.

Cash & Marketable Securities
HKD 369.41M
Total Debt
HKD 116.76M
Net Cash
HKD 252.65M
Net Cash Per Share
HKD 0.12
Tangible Book Value Per Share
HKD 0.29

Margins

Gross margin is 11.12%, with operating margin of 2.79%, and net profit margin of 1.58%.

Gross Margin
11.12%
Operating Margin
2.79%
Pretax Margin
2.18%
Net Profit Margin
1.58%
EBITDA Margin
4.71%
EBIT Margin
3.31%

Analyst Forecast

The average price target for Sinco Pharmaceuticals Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-20.04%
EPS Growth Forecast
-25.66%

Scores

Smart Score
―
AI Score
52